CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

Neehar D. Parikh, Peng Zhang, Amit G. Singal, Brian A. Derstine, Venkat Krishnamurthy, Pranab Barman, Akbar K. Waljee, Grace L. Su

Cancer Research and Treatment. 2018;50(2):530-537. Published online 2017 June 1 DOI: https://doi.org/10.4143/crt.2017.156

CT texture analysis in predicting treatment response and survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization

He An, Inderjeet Bhatia, Chuanmiao Xie

. 2022;

Link1 Link2

Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

Neehar D. Parikh, Peng Zhang, Amit G. Singal, Brian A. Derstine, Venkat Krishnamurthy, Pranab Barman, Akbar K. Waljee, Grace L. Su

Cancer Research and Treatment. 2018;50(2):530-537

Link1

Link2 Link3

An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma

David J. Pinato, Rohini Sharma

Translational Research. 2012;160(2):146-152

Link1 Link2

Cost-effectiveness analysis of transarterial chemoembolization combined with stereotactic body radiation therapy versus transarterial chemoembolization for inoperable hepatocellular carcinoma: A markov modelling study

haiyin wang, Vijay Gc, Sheng Zhang, chunlin Jin

. 2020;

Link1 Link2

Transarterial Chemoembolization Improves Survival in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors

Yue Hu, Tao Pan, Xi Cai, Quansheng He, Yubao Zheng, Bing Hu, Ting Jiang, Mingsheng Huang, Zaibo Jiang, Junwei Chen, Chun Wu

. 2021;

Link1 Link2

Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101

Chao-Bin He, Xiao-Jun Lin

PLOS ONE. 2017;12(3):e0174769

Link1

Survival Rates in Hepatocellular Carcinoma Patient Treated by Transarterial Chemoembolization: Comparison withOperable and Inoperable Cases

Tae Yong Moon

Journal of the Korean Radiological Society. 1998;38(4):629

Link1 Link2 Link3

Comparison of treatment response, survival profiles as well as safety profiles between CalliSpheres® microspheres transarterial chemoembolization and conventional transarterial chemoembolization in huge hepatocellular carcinoma

Xuhua Duan, Juanfang Liu, Xinwei Han, Jianzhuang Ren, Hao Li, Fengyao Li, Shuguang Ju

. 2020;

Link1 Link2

Post-Intervention Plasma IL-10 Level Predicts Early Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

Mengxuan Shan, Jing Fan, Xinmiao Xiong, Na Liu, Lili Wang, Wei Ye

Hepatitis Monthly. 2022;22(1):

Link1

Link2

Nonresectable Hepatocellular Carcinoma: Long-term Toxicity in Patients Treated with Transarterial Chemoembolization—Single-Center Experience

T.G. Walker

Yearbook of Diagnostic Radiology. 2009;2009:212-214

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.